Stephanie J. Cragg is a professor of neuroscience at the University of Oxford.[1] She is also a tutor for medicine at the college Christ Church, Oxford.[2]

Cragg studied Natural Sciences at the University of Cambridge, followed by a DPhil at the University of Oxford Department of Pharmacology.[3] Her supervisors there were Baroness Professor Susan Greenfield (Oxford) and Margaret Rice (New York University).[4]

Work

Her work focusses on the neuronal pathways that are disruption in Parkinson's disease, drug addiction and other disorders.[2][3] This work focusses on the regulation of dopaminergic transmission.

Cragg's work includes the study of how the inhibitory neurotransmitter GABA regulates dopaminergic transmission and the importance of this for Parkinson's disease.[5][6] Her most cited work relates to the cholinergic (nicotinic) regulation of dopamine transmission.[7][8]

Scientific leadership

Scientific journals

  • Addiction Neuroscience[9]
  • ACS Chemical Neuroscience[10]
  • npj Parkinson's Disease[11]

Societies

Engagement with scientific societies include:

  • President-elect of the Society for Monitoring Molecules in Neuroscience (2022-2024)[12]
  • College of Experts for Parkinson's UK[13]

Keynote lectures

  • EJN Special Feature Plenary Lecture, FENS Forum 2018, Berlin, Germany[14]
  • Keynote Speaker, ViDA 2020 - Virtual Dopamine Conference[15]

References

  1. ↑ "Recognition of Distinction: Successful applicants 2014" Archived 16 September 2015 at the Wayback Machine, The University of Oxford Gazette, no. 5076, 6 November 2014. Retrieved 20 November 2016.
  2. 1 2 "Professor Stephanie Cragg | Christ Church, University of Oxford". www.chch.ox.ac.uk. Retrieved 18 October 2023.
  3. 1 2 "Stephanie Cragg". www.dpag.ox.ac.uk. Retrieved 18 October 2023.
  4. ↑ Helmreich, Dana L. (July 2018). "Profiles of Women in Science: Prof. Stephanie Cragg of the University of Oxford, Oxford, UK". European Journal of Neuroscience. pp. 1723–1727. doi:10.1111/ejn.14058. Retrieved 18 October 2023.
  5. ↑ Roberts, Bradley M.; Doig, Natalie M.; Brimblecombe, Katherine R.; Lopes, Emanuel F.; Siddorn, Ruth E.; Threlfell, Sarah; Connor-Robson, Natalie; Bengoa-Vergniory, Nora; Pasternack, Nicholas; Wade-Martins, Richard; Magill, Peter J.; Cragg, Stephanie J. (2 October 2020). "GABA uptake transporters support dopamine release in dorsal striatum with maladaptive downregulation in a parkinsonism model". Nature Communications. 11 (1). doi:10.1038/s41467-020-18247-5.
  6. ↑ Cramb, Kaitlyn M L; Beccano-Kelly, Dayne; Cragg, Stephanie J; Wade-Martins, Richard (1 August 2023). "Impaired dopamine release in Parkinson's disease". Brain. 146 (8): 3117–3132. doi:10.1093/brain/awad064.
  7. ↑ Threlfell, Sarah; Lalic, Tatjana; Platt, Nicola J.; Jennings, Katie A.; Deisseroth, Karl; Cragg, Stephanie J. (July 2012). "Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons". Neuron. 75 (1): 58–64. doi:10.1016/j.neuron.2012.04.038.
  8. ↑ Rice, Margaret E; Cragg, Stephanie J (June 2004). "Nicotine amplifies reward-related dopamine signals in striatum". Nature Neuroscience. 7 (6): 583–584. doi:10.1038/nn1244.
  9. ↑ "Addiction Neuroscience | Journal | ScienceDirect.com by Elsevier". www.sciencedirect.com.
  10. ↑ "Editors & Editorial Board". ACS Publications.
  11. ↑ "npj Parkinson's Disease". Nature. 10 July 2023. Retrieved 18 October 2023.
  12. ↑ "About". MMiN. Retrieved 18 October 2023.
  13. ↑ "Parkinson's UK College of Experts". Parkinson's UK. Retrieved 18 October 2023.
  14. ↑ "Feature Plenary Lecture, FENS Forum 2018".
  15. ↑ "Speakers". VIDA 2020.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.